Cargando…

The detection of anti-dengue virus IgM in urine in participants enrolled in an acute febrile illness study in Puerto Rico

BACKGROUND: Dengue is an important arboviral disease with about 100 million dengue cases per year, of which, ~5% result in severe disease. Clinical differentiation of dengue from other acute febrile illnesses (AFI) is difficult, and diagnostic blood tests are costly. We evaluated the utility of anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Caraballo, Elba, Poole-Smith, B. Katherine, Tomashek, Kay M., Torres-Velasquez, Brenda, Alvarado, Luisa I., Lorenzi, Olga D., Ramos, Carmen, Carrión, Jessica, Hunsperger, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988914/
https://www.ncbi.nlm.nih.gov/pubmed/31995560
http://dx.doi.org/10.1371/journal.pntd.0007971
_version_ 1783492329215098880
author Caraballo, Elba
Poole-Smith, B. Katherine
Tomashek, Kay M.
Torres-Velasquez, Brenda
Alvarado, Luisa I.
Lorenzi, Olga D.
Ramos, Carmen
Carrión, Jessica
Hunsperger, Elizabeth
author_facet Caraballo, Elba
Poole-Smith, B. Katherine
Tomashek, Kay M.
Torres-Velasquez, Brenda
Alvarado, Luisa I.
Lorenzi, Olga D.
Ramos, Carmen
Carrión, Jessica
Hunsperger, Elizabeth
author_sort Caraballo, Elba
collection PubMed
description BACKGROUND: Dengue is an important arboviral disease with about 100 million dengue cases per year, of which, ~5% result in severe disease. Clinical differentiation of dengue from other acute febrile illnesses (AFI) is difficult, and diagnostic blood tests are costly. We evaluated the utility of anti-DENV IgM in urine to identify dengue cases among AFI patients enrolled in a clinical study. METHODS: Between May 2012-March 2013, 1538 study participants with fever for ≤7 days were enrolled, a medical history was obtained, and serum and urine specimens were collected. Serum was tested for DENV RNA and anti-DENV IgM. Urine was tested for anti-DENV IgM, and its sensitivity and specificity to detect sera laboratory-positive dengue cases were calculated. We evaluated if urine anti-DENV IgM positivity early (≤5 days post-illness onset [DPO]) and late (6–14 DPO) in the clinical course was associated with dengue severity. RESULTS: Urine anti-DENV IgM sensitivity and specificity were 47.4% and 98.5%, respectively, when compared with serum anti-DENV IgM ELISA results, and 29.7% and 91.1% when compared with serum rRT-PCR results. There was no correlation between urine anti-DENV IgM positivity and patient sex or pre-existing chronic disease. Early in the clinical course, a significantly higher proportion of those who developed dengue with warning signs had anti-DENV IgM in their urine when compared to those without warning signs (20.4% vs. 4.3%). There was no difference in the proportion with urine anti-DENV IgM positivity between severity groups late in the clinical course. CONCLUSION: While detection of urine anti-DENV IgM lacked adequate diagnostic sensitivity, it is a highly specific marker for laboratory-positive dengue, and its presence early in the clinical course may distinguish those with more severe disease. Further assessment of urine anti-DENV IgM by DPO is warranted to determine its utility as an early diagnostic (and possibly prognostic) marker for dengue.
format Online
Article
Text
id pubmed-6988914
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-69889142020-02-20 The detection of anti-dengue virus IgM in urine in participants enrolled in an acute febrile illness study in Puerto Rico Caraballo, Elba Poole-Smith, B. Katherine Tomashek, Kay M. Torres-Velasquez, Brenda Alvarado, Luisa I. Lorenzi, Olga D. Ramos, Carmen Carrión, Jessica Hunsperger, Elizabeth PLoS Negl Trop Dis Research Article BACKGROUND: Dengue is an important arboviral disease with about 100 million dengue cases per year, of which, ~5% result in severe disease. Clinical differentiation of dengue from other acute febrile illnesses (AFI) is difficult, and diagnostic blood tests are costly. We evaluated the utility of anti-DENV IgM in urine to identify dengue cases among AFI patients enrolled in a clinical study. METHODS: Between May 2012-March 2013, 1538 study participants with fever for ≤7 days were enrolled, a medical history was obtained, and serum and urine specimens were collected. Serum was tested for DENV RNA and anti-DENV IgM. Urine was tested for anti-DENV IgM, and its sensitivity and specificity to detect sera laboratory-positive dengue cases were calculated. We evaluated if urine anti-DENV IgM positivity early (≤5 days post-illness onset [DPO]) and late (6–14 DPO) in the clinical course was associated with dengue severity. RESULTS: Urine anti-DENV IgM sensitivity and specificity were 47.4% and 98.5%, respectively, when compared with serum anti-DENV IgM ELISA results, and 29.7% and 91.1% when compared with serum rRT-PCR results. There was no correlation between urine anti-DENV IgM positivity and patient sex or pre-existing chronic disease. Early in the clinical course, a significantly higher proportion of those who developed dengue with warning signs had anti-DENV IgM in their urine when compared to those without warning signs (20.4% vs. 4.3%). There was no difference in the proportion with urine anti-DENV IgM positivity between severity groups late in the clinical course. CONCLUSION: While detection of urine anti-DENV IgM lacked adequate diagnostic sensitivity, it is a highly specific marker for laboratory-positive dengue, and its presence early in the clinical course may distinguish those with more severe disease. Further assessment of urine anti-DENV IgM by DPO is warranted to determine its utility as an early diagnostic (and possibly prognostic) marker for dengue. Public Library of Science 2020-01-29 /pmc/articles/PMC6988914/ /pubmed/31995560 http://dx.doi.org/10.1371/journal.pntd.0007971 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Caraballo, Elba
Poole-Smith, B. Katherine
Tomashek, Kay M.
Torres-Velasquez, Brenda
Alvarado, Luisa I.
Lorenzi, Olga D.
Ramos, Carmen
Carrión, Jessica
Hunsperger, Elizabeth
The detection of anti-dengue virus IgM in urine in participants enrolled in an acute febrile illness study in Puerto Rico
title The detection of anti-dengue virus IgM in urine in participants enrolled in an acute febrile illness study in Puerto Rico
title_full The detection of anti-dengue virus IgM in urine in participants enrolled in an acute febrile illness study in Puerto Rico
title_fullStr The detection of anti-dengue virus IgM in urine in participants enrolled in an acute febrile illness study in Puerto Rico
title_full_unstemmed The detection of anti-dengue virus IgM in urine in participants enrolled in an acute febrile illness study in Puerto Rico
title_short The detection of anti-dengue virus IgM in urine in participants enrolled in an acute febrile illness study in Puerto Rico
title_sort detection of anti-dengue virus igm in urine in participants enrolled in an acute febrile illness study in puerto rico
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988914/
https://www.ncbi.nlm.nih.gov/pubmed/31995560
http://dx.doi.org/10.1371/journal.pntd.0007971
work_keys_str_mv AT caraballoelba thedetectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico
AT poolesmithbkatherine thedetectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico
AT tomashekkaym thedetectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico
AT torresvelasquezbrenda thedetectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico
AT alvaradoluisai thedetectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico
AT lorenziolgad thedetectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico
AT ramoscarmen thedetectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico
AT carrionjessica thedetectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico
AT hunspergerelizabeth thedetectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico
AT caraballoelba detectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico
AT poolesmithbkatherine detectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico
AT tomashekkaym detectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico
AT torresvelasquezbrenda detectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico
AT alvaradoluisai detectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico
AT lorenziolgad detectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico
AT ramoscarmen detectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico
AT carrionjessica detectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico
AT hunspergerelizabeth detectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico